Cardiovascular effects of neuropeptide FF antagonists

被引:16
作者
Prokai, Laszlo
Zharikova, Aleutina D.
Juhasz, Attila
Prokai-Tatrai, Katalin
机构
[1] Univ Florida, Coll Pharm, Dept Med Chem, Gainesville, FL 32610 USA
[2] Univ Florida, McKnight Brain Inst, Gainesville, FL 32610 USA
[3] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA
[4] Univ Debrecen, Sch Med, Dept Med 1, Debrecen, Hungary
关键词
neuropeptide FF; antagonist; hemodynamic parameters; rat;
D O I
10.1016/j.peptides.2005.06.032
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The neuropeptide FF (NPFF) antagonist desaminotyrosyl-Phe-Leu-Phe-Gln-Pro-Gln-Arg-NH2 dose-dependently reversed NPFF-induced elevation of blood pressure in anesthetized rats after intravenous injection without causing a significant change of blood pressure and heart rate by itself. However, another antagonist dansyl-Pro-Gln-Arg-NH2 produced a significant drop of the mean arterial pressure only at a large dose (10 mu mol/kgbody weight), but reversal of the NPFF-induced hypertension was modest. Consequently and contrary to the conclusions of a previous study, NPFF antagonists cannot be identified simply by measuring the changes in the hemodynamic parameters upon the injection of the compounds alone and, without a subsequent NPFF challenge. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:1015 / 1019
页数:5
相关论文
共 21 条
[1]  
ALLARD M, 1995, J PHARMACOL EXP THER, V274, P577
[2]   Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor [J].
Elshourbagy, NA ;
Ames, RS ;
Fitzgerald, LR ;
Foley, JJ ;
Chambers, JK ;
Szekeres, PG ;
Evans, NA ;
Schmidt, DB ;
Buckley, PT ;
Dytko, GM ;
Murdock, PR ;
Milligan, G ;
Groarke, DA ;
Tan, KB ;
Shabon, U ;
Nuthulaganti, P ;
Wang, DY ;
Wilson, S ;
Bergsma, DJ ;
Sarau, HM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (34) :25965-25971
[3]   Functional properties of PFR(Tic)amide and BIBP3226 at human neuropeptide FF2 receptors [J].
Engström, M ;
Wurster, S ;
Savola, JM ;
Panula, P .
PEPTIDES, 2003, 24 (12) :1947-1954
[4]   Rodent strain differences in the NPFF1 and NPFF2 receptor distribution and density in the central nervous system [J].
Gouardères, C ;
Faura, CC ;
Zajac, JM .
BRAIN RESEARCH, 2004, 1014 (1-2) :61-70
[5]   Detailed distribution of neuropeptide FF receptors (NPFF1 and NPFF2) in the rat, mouse, octodon, rabbit, guinea pig, and marmoset monkey brains:: A comparative autoradiographic study [J].
Gouardères, C ;
Puget, A ;
Zajac, JM .
SYNAPSE, 2004, 51 (04) :249-269
[6]   The cardiovascular effects of PFRFamide and PFR(Tic)amide, a possible agonist and antagonist of neuropeptide FF (NPFF) [J].
Huang, EYK ;
Li, JY ;
Tan, PPC ;
Wong, CH ;
Chen, JC .
PEPTIDES, 2000, 21 (02) :205-210
[7]   Functional characterization of a human receptor for neuropeptide FF and related peptides [J].
Kotani, M ;
Mollereau, C ;
Detheux, M ;
Le Poul, E ;
Brézillon, S ;
Vakili, J ;
Mazarguil, H ;
Vassart, G ;
Zajac, JM ;
Parmentier, M .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 (01) :138-144
[8]   Cardiovascular effects induced by the stimulation of neuropeptide FF receptors in the dorsal vagal complex: An autoradiographic and pharmacological study in the rat [J].
Laguzzi, R ;
Nosjean, A ;
Mazarguil, H ;
Allard, M .
BRAIN RESEARCH, 1996, 711 (1-2) :193-202
[9]   ANALOG OF NEUROPEPTIDE-FF ATTENUATES MORPHINE ABSTINENCE SYNDROME [J].
MALIN, DH ;
LAKE, JR ;
LEYVA, JE ;
HAMMOND, MV ;
ROGILLIO, RB ;
ARCANGELI, KR ;
LUDGATE, K ;
MOORE, GM ;
PAYZA, K .
PEPTIDES, 1991, 12 (05) :1011-1014
[10]   SUBCUTANEOUS INJECTION OF AN ANALOG OF NEUROPEPTIDE FF PREVENTS NALOXONE-PRECIPITATED MORPHINE ABSTINENCE SYNDROME [J].
MALIN, DH ;
LAKE, JR ;
SMITH, DA ;
JONES, JA ;
MOREL, J ;
CLAUNCH, AE ;
STEVENS, PA ;
PAYZA, K ;
HO, KK ;
LIU, J ;
HAM, I ;
BURGESS, K .
DRUG AND ALCOHOL DEPENDENCE, 1995, 40 (01) :37-42